化学查确定了p38 MAPK抑制作为组合性SMA治疗的候选神经保护策略
bioRxiv : the preprint server for biology
|April 16, 2025
概括
抑制p38 MAPK通过改善运动功能,在脊柱肌肉缩 (SMA) 中提供神经保护. 与SMN增强药物的联合疗法在SMA小鼠中显示出协同效益.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊髓肌肉缩 (SMA) 是一种神经退行性疾病,源于生存运动神经元 (SMN) 蛋白质缺乏.
- 识别SMA疾病修饰剂对于开发超越SMN上调的新型治疗策略至关重要.
研究的目的:
- 为了识别SMN生物学中的化学修饰剂.
- 为了研究p38 MAPK在SMA发病过程中的作用.
- 评估p38 MAPK抑制作为SMA的治疗策略.
主要方法:
- 基于细胞的表型屏幕被用来识别化学修饰剂.
- 在 SMA 模型中评估了 p38 MAPK 激活.
- 在SMA小鼠中测试了p38 MAPK的药理抑制.
- 评估了使用SMN诱导药物和p38 MAPK抑制剂 (MW150) 的组合治疗.
主要成果:
- 抑制p38 MAPK的抑制剂抑制了SMN缺乏细胞中的增殖缺陷.
- 缺少SMN导致p38 MAPK的激活.
- 药理上抑制p38 MAPK通过SMN独立的神经保护改善了SMA小鼠的运动功能.
- 组合治疗显示出协同效应,增强运动功能,体重增加和生存.
结论:
- p38 MAPK通路是SMA的可行的治疗标.
- MW150显示出作为SMN独立神经保护的药理学剂的潜力.
- 涉及p38 MAPK抑制和SMN诱导的组合疗法为SMA治疗提供了一个有前途的方法.
更多相关视频
相关概念视频
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...


